The Swiss Biotech Directory

4bases is a company active in the fields of prevention and precision medicine. 4bases is a certified company working accordingly to the IVDR regulation. Our products are reagent kits for platform-independent New Generation DNA Sequencing (NGS), data analysis software and diagnostic protocols.

4G Clinical is a global leader in randomisation and trial supply management and supply forecasting optimisation software for the life sciences industry, offering a fully cloud-based, 100% configurable solution using natural language processing to accelerate clinical trials.

7AlpsBio Consulting Services offers expertise in healthcare in strategic, operational, project support and a management know-how with a focus on ATMPs, biopharmaceuticals and life sciences in (pre)clinical development, GMP manufacturing from clinical trials to commercialization.

Abbmira therapeutics is a Basel based biotech founded by experience scientists and entrepreneurs in September 2024. Abbmira develops first-in-class small molecules to fine-tune native immunity to treat difficult-to-treat cancers and chronic diseases.

abc biopply AG is pioneering NAM technologies and organoid CRO services that boost in vitro studies for drug discovery and development to IND relevance using its proprietary 3D CoSeedis Multi-Organoid in chip Technology™ on clinically relevant disease models (oncology, neurology, obesity and others)

AC Immune SA is a clinical-stage biopharma that aims to become a global leader in precision medicine for neurodegenerative diseases, including Alzheimer’s, Parkinson’s, and NeuroOrphan indications. The Company has two clinically validated technology platforms, SupraAntigen® and Morphomer®.

Accelsiors is a global, full-service clinical research organization delivering end-to-end trial solutions under one roof. For over 20 years, we’ve supported biopharma with scientific, regulatory, legal, and operational expertise, driving efficient, high-quality clinical development worldwide.

ACROBiosystems Group, founded in 2010 and listed in 2021, is a biotechnology company aimed at being a cornerstone of the global biopharmaceutical and health industries by providing products and business models innovation.

Addex Therapeutics is a clinical-stage biopharmaceutical company focused on developing a portfolio of novel small molecule allosteric modulators for neurological disorders.

ADIENNE is an integrated biopharmaceutical group of companies based in Lugano, Switzerland, with a proprietary portfolio of orphan-designated marketed medicinal product, clinical and preclinical product candidates focusing on critical conditions of high unmet medical needs.

Akceso Advisors: specialist pricing, reimbursement & market access advisor firm. For your buy/sell side 'Evidence-based Asset Valuation' and payer-relevant input into your development plan design. Akceso Advisors: Catalysts to patient access and pricing success. For better public health worldwide.

Alentis Therapeutics is a clinical-stage biotechnology company developing first-in-class therapies targeting claudin-1 for a range of fibrosis and oncology indications. We are rapidly advancing our pipeline of antibodies and antibody-drug conjugates through clinical development.

We develop animal-based products via cell cultivation, combining proprietary animal cell biology with scalable bioprocessing at favorable unit economics. The platform starts with the world's first cultivated whole-cut beef and expands into functional applications, like cell-derived collagen.

At Alithea Genomics we develop, produce and commercialize cutting-edge solutions for drug and biomarker discovery based on gene expression. Our products provide high throughput and cost-efficiency, which is ideal for large-scale projects such as drug screening and biomarker discovery.

Allegria Therapeutics was founded in Basel in 2023. Pursuing a differentiated portfolio of proprietary therapeutic approaches around biological targets that selectively modulate mast cells, Allegria plans to redefine the treatment landscape for allergy and mast cell-mediated inflammatory diseases.

Almac provides the most comprehensive global clinical supply chain solution in the marketplace. Guided by our extensive supply experience, we provide the physical resources and supportive technologies that ensure your clinical supply chain continually delivers across the globe.

AlphaMol is an AI-based bio-pharmaceutical company focusing on G protein-coupled receptor drug discovery. The Cofounders of AlphaMol are leading scientists in the area of GPCRs. Many essential molecular mechanisms and biotechnology were invented by the members of AlphaMol.

Alpinuity Bio aims to provide consulting services in the field of biopharmaceutical R&D specifically in translational science and biomarkers. We advise and support investors, start-ups and established companies in due diligence, scientific and technical aspects.  

Altasciences is a forward-thinking CRO offering a flexible approach to preclinical and clinical pharmacology studies, including formulation, manufacturing and analytical services. Altasciences’ solutions include preclinical safety testing, clinical pharmacology and POC, bioanalysis, and CRO services

Altorfer Engineering is a specialized contractor and consulting company. We provide expertise in engineering and project management services, and technology transfers. Our focus is on developing and managing aseptic formulation and fill-finish processes tailored to your receiving sites.

AlveoliX provides in-vitro solutions based on proprietary and unique organ-on-chip technologies aimed at improving preclinical decision-making and thus reducing drug development costs.

Swiss health science co. pioneering clinically proven products to promote cellular health and longevity. The company’s proprietary nutrient, Mitopure, is clinically shown to combat age-related declines in mitochondrial health and muscle function. Nestlé Health Science is a global strategic partner.

Amphasys is a leading provider of label-free cell analysis solutions for cells from 1 to 250 um. Characteristics such as size, count and morphology, viability, metabolic and health status are determined real-time. Amphasys is market leader in pollen analysis in the seed industry.

Amphilix AG is a Basel-based biotech developing next-generation radioligand therapies using a proprietary 3D linker platform and small-molecule ligands. Its clinical-stage lead AMX-0053 targets a protein for colorectal cancer and is ready for First-in-Human imaging. The company seeks CHF 9m Seed.

Amporin is developing a new class of small molecule amyloid pore inhibitors as the first potential acute oral drugs to stop and reverse the progression of deadly degenerative diseases. Our vision is to cure 6 major degenerative diseases with a simple pill, starting with Parkinson’s disease.

Anaveon is a global clinical stage biopharmaceutical company that specializes in developing novel treatments for diseases with high unmet needs. Our team is driven to make this vision a reality: we are committed to transforming immunological insights into life-changing therapies.

As a health company, we envision empowering global well-being by pioneering biological solutions drawn from nature. Our mission: Unlock the full potential of exDNA across diverse indications. Our AND Technology Platform has the primary focus on controlling disease caused by pathogenic bacteria.

ANSEA is a global consulting firm enabling pharmaceuticals, biopharmaceuticals and medical device companies navigate through the complexities of healthcare systems across the world and helping bring their solutions to patients.

Our platform enables efficient, tunable multiplex gene silencing, modulating multiple targets in one construct for superior safety and potency over traditional editing. Its modular design suits various cell and gene engineering applications.

Apricot BIO is a first-time launcher of a Functional Precision Oncology platform performing deep molecular phenotyping of drug responses for personalised therapy recommendations for early to late-stage clinical decision-making leading to more precise, evidenced-based recommendations for doctors.

Artidis® is a pioneering clinical stage health technology company that aims to set the gold standard in tissue analysis and therapy optimization. Artidis focuses its efforts on solid tumors to enhance responses to chemo, immuno, and cell therapies, driving precision in cancer care.

Asceneuron is a clinical stage biotech company focused on the development of orally bioavailable therapeutics for debilitating neurodegenerative disorders with high unmet medical need, including orphan tauopathies, Alzheimer’s and Parkinson’s disease.

Asemblis is a Swiss TechBio company developing scalable, human-relevant in vitro models for obesity and metabolic disorders. The company partners with industry and research organizations to support translational R&D and decision-making in drug development

At ATANIS Biotech AG, our mission is to revolutionize the way allergies are diagnosed and thereby to improve treatment success Our novel cell-based assay allows us to quantify patients allergic status with unparalleled diagnostic accuracy, without needing to expose patients to the culprit allergen.

Athebio develops ultra-stable biotherapeutics using proprietary Athebody® DARPin molecules with high affinity and specificity. We partner on radiotherapeutics, T cell engagers, targeted delivery (LNP/AAV/oligo) and affinity ligands, enabling breakthrough therapeutic strategies.

Atopia Therapeutics is developing a revolutionary treatment for allergic diseases such as atopic dermatitis, allergic asthma, food allergies and hay fever based on the discovery that a bacterium present in the human stomach produces a protein that protects us from these diseases.

Aukera builds a discovery engine that allows designing new classes of drugs to selectively target different branches of the mTOR pathway. The lead program selectively targets mTOR complex 1 to treat rare diseases, cancer, and neurodegenerative diseases, and uniquely addresses unmet medical needs.

Aurealis Therapeutics is a Swiss-Finnish Cell and Gene Therapy Platform Company. Our multi-target scalable low COGS products, based on genetically engineered lactic acid bacteria, addresses unmet medical needs: Chronic Wounds - Diabetic Foot Ulcers, Venous Ulcers - Cancers - Ovarian, Peritoneal

AVEctivate supports pharma, biotech and diagnostic companies aiming to make a positive difference to patients, and health care providers by offering strategic consulting, project management and interim management. Believing that change is the only constant, we embrace the future as an opportunity.

Avenza Consulting has been created to support pharma, biotech companies, startups to develop and grow by offering Strategic Consulting, R&D services to foster innovation, Program & Portfolio Management to optimize projects, and Operational Excellence to streamline processes.

Axcura AG is a Swiss life-science company specializing in the sourcing, qualification, and distribution of pharma and biotech raw materials. We combine Swiss quality, regulatory excellence, and global supplier networks to secure reliable, compliant supply chains.

Axxam S.p.A. is a CRO delivering integrated early drug discovery, from target identification to lead generation. Through its DiscoveryMAXX platform, it supports pharma, biotech, start-ups, and academia with biology-driven solutions across all therapeutic areas and target classes.

Azafaros is a clinical-stage biotech company addressing rare genetic lysosomal storage disorders with oral small molecules, including nizubaglustat. Our focus is on developing disease-modifying therapies for patients with, among others, GM1 and GM2 gangliosidoses, and Niemann-Pick Type C disease.

AzureCell is a Swiss regenerative cell therapy company leveraging two decades of pioneering neuroscience and cell‑engineering research at the University of Geneva to advance next‑generation allogeneic cell‑replacement therapies for the brain.

Baccinex is a CDMO specialized in the manufacturing of sterile (liquid & lyophilized) Drug Product. Our service includes: scale-up from laboratory to GMP, GMP manufacturing, clinical packaging, QC release analytics, stability studies programs, GMP storage. Baccinex was acquired by Adragos Pharma in 2024.

Baliopharm AG, is a biotechnology company focusing on the development of innovative therapeutics for the treatment of chronic liver diseases, immune mediated inflammatory diseases, as well as for cancer.

Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN) is a commercial-stage biopharmaceutical company headquartered in Switzerland. Basilea is committed to discovering, developing and commercializing innovative drugs to meet the needs of patients with severe bacterial and fungal infections.

Bavarian Nordic is a fully integrated vaccine company focused on the development, manufacturing and commercialization of life-saving vaccines. Our manufacturing site for oral vaccines is located in Thörishaus, 15 km southwest of Bern.

At BD, we are committed to sustainable healthcare. We are inspired by childhood to be innovative thinkers, to be ambitious in our ways of caring about the patients and healthcare professionals of tomorrow.

BeOne Medicines is a global oncology company developing innovative, affordable, and accessible cancer treatments worldwide. We expedite development of our diverse pipeline of novel therapeutics through strong internal capabilities and collaborations. Our 11,000 colleagues span six continents.

Betta Scientific is a Life Sciences consultancy. We support start-ups and established companies in entering international markets. Our clients rely on us to design and execute global go-to-market strategies, build international distribution networks, and accelerate revenue generation across borders.

BigOmics Analytics is a Swiss bioinformatics company accelerating omics data analysis for precision medicine. Its cloud-native platform, Omics Playground, empowers researchers to visualize, interpret and share complex omics data fostering efficient collaboration.

Bio-Rad Laboratories continues to play a leading role in the advancement of scientific discovery by offering a broad range of innovative tools and services to the life science research and clinical diagnostics markets.

BioArk drives innovation and business growth from early stages to commercialization. With two technology parks in Valais and over 10,000 jobs, our ecosystem offers cutting-edge facilities, expert coaching, funding support, and a strong industrial and scientific network.

Immune response on a chip!

We at Bioengineering AG design and build customized equipment to improve bioproduction efficiency in biotech, novel food, and biopharma plants. Our engineering teams develop reliable bioreactors and fermenters, from lab scale to production, for clients worldwide. Trusted for over 50 years.

At Biogen, we develop, market and manufacture therapies for people living with serious neurological, autoimmune and rare diseases.

We "think data" and "speak biology", partnering with our clients to transform lives. Our team combines deep biological knowledge with proven expertise in AI & bioinformatics to tackle complex data challenges. Via our AI-native Bio|Verse platform, we accelerate biomarker discovery & drug development.

Blanc-Labo has been installing and maintaining in Switzerland complex equipments for laboratories for the past 35 years. We have about 4000 customers in Switzerland and France: biotechs, universities, industries. We are based in Lonay near Lausanne.

Blueprint Medicines is a global precision therapy company inventing life-changing therapies for people with cancer and blood disorders. Applying an approach that is both precise and agile, our medicines selectively target genetic drivers, with the goal of staying one step ahead of disease.

I work WITH my clients as a freelance science business development project manager. Having said that, Boehler Life Science Advice is not typical consultancy, even though strategic planning and execution is an important part of supporting my clients.

Bright Peak Therapeutics is a biotechnology company advancing a portfolio of multifunctional immunotherapies. We leverage our world-class protein engineering & conjugation platform to generate novel protein therapeutics for cancer and other indications. Bright Peak is located in Basel and San Diego.

Bromatech has been engaged for more than 25 years in the study and development of targeted food supplements based on specific strains of lactic acid bacteria, antioxidants and essential fatty acids which are able to interact with the precious heritage of the human microbiota.

CALDRE is a Switzerland based biotech spin-out focussed to revolutionize the way cholestatic-and fibrotic diseases are treated. We develop precise, liver-directed GalNAc-siRNAs to restore bile flow and prevent fibrosis - placing CALDRE in the fast-growing RNA-therapeutics segment of biotech.

Calliditas is a commercial stage biopharmaceutical company focused on novel treatments in orphan indications, with an initial focus on renal and hepatic diseases with significant unmet medical needs. In 2021, Calliditas acquired Genkyotex, specializing company in NOX therapies, French & Swiss based.

Canlion AG supports biotech companies in aspects of business development, M&A, financing and strategic development and positioning.

Catalent is the global leader in enabling pharma, cell & gene therapy and biopharma partners to optimize product development, launch, and full life-cycle supply for patients around the world. Catalent helps accelerate over 1,000 partner programs every year for partners of all sizes.

We are experts in obtaining funding for biomedical and healthcare innovations, as well as for ICT, eHealth and big data fields projects. We help leading researchers and companies secure financing for ambitious R&D projects, from early stage pre-clinical research up to clinical stage development.

Ceidos is a Swiss biotech company developing the C-Netics, an innovative device for automated cell culture monitoring. Their mission is to optimize bioproduction processes for modern treatments through automation and innovative technologies.

Our comprehensive services for early phase drug development, enables you to get your product to market faster. Our state-of-the-art Zürich laboratory focuses on science, compliance and speed to deliver high-quality data analysis. We apply our 40+ years of experience to exceed your expectations.

Cellerys AG is a clinical stage biotechnology company, developing immune tolerance therapeutics for the treatment of multiple sclerosis (MS). Antigenic peptides identified from MS patients are coupled to autologous red blood cells which, when reinfused, restore immune tolerance. in 2021 the company entered a

Centenara is an integrated biotechnology platform company that develops and improves therapies and technologies to promote healthy aging and prolong lifespan. We provide start-up coaching and funding to entrepreneurial scientists to co-create therapies that benefit our aging population.

Cerdia, headquartered in Basel, is a pioneer in cellulose acetate tow since 1912 and a global quality and innovation leader of filter tow for cigarette manufacture. We are developing innovative applications and processes that will define Cellulose Acetate as a sustainable raw material in the future.

Cetacea Clinical offers Clinical Operations Services and functional services, including trial management, regulatory compliance, data management, and quality oversight. Our robust Quality Management System ensures efficient, high-quality clinical trials from start to finish.

chAIron blends AI with deep life-science expertise to accelerate R&D. We identify and prioritize new indications, strengthen evidence, de-risk development decisions, and unlock the full potential of pharma and biotech assets—helping deliver better outcomes for patients.

Chemgineering is a global consulting and planning company with a focus on the GxP-regulated environment. From consulting to concept studies and further on to turnkey solutions, we offer the full range of services for the life sciences industries.

We develop ADCs and radioligands, leveraging our conjugation platform. We create new treatments offering hope to patients that suffer from aggressive cancer with poor prognosis.

Citeline, a Norstella company, powers a full suite of complementary business intelligence offerings to meet the evolving needs of life science professionals to accelerate the connection of treatments to patients and patients to treatments.

ClearView helps life science clients build robust strategies. Our work spans asset, franchise, and corporate-level strategy across therapeutic areas, lifecycle stages, and regions of the world.

Caidya is a multi-therapeutic clinical research organization serving innovators worldwide. Focused on delivery excellence and an elevated customer experience, we offer a wide range of clinical services and vast therapeutic expertise.

You are planning your first trial and need to build up a ClinOps team? You would like your trial to run more efficiently? Do you need support to prepare for an inspection or develop SOPs? You will find the collaboration with us useful to obtain advice and create a strategy for long-term success.

CMC & More delivers hands-on CMC, regulatory, and quality expertise for biotech and pharma. We bridge discovery to first-in-human trials and beyond with GMP-compliant CMC strategies that derisk development and transform complex products into approval-ready assets.

We want to be strategic collaborator with executive management and empower in-house IR/PR professionals to help you build lasting and mutually beneficial relationships with investors, partners, media, and other stakeholders.

Complyomics supports Life Sciences companies in core areas as: Build and maintain robust Quality Systems in compliance with regulatory requirements. Provide externalized QA. Audits Develop expertise in Bioanalytical / Analytical areas Identify / assess / supervise sub-contractors Due diligence

CROss Alliance® is a Swiss CRO specialised in early clinical development. With more than 500 trials performed at CROSS phase I unit or in selected EU sites, we are experts in PK, bioequivalence, first in man, tolerability studies including cardiac safety and efficacy models in healthy volunteers.

CSL (ASX:CSL; USOTC:CSLLY) – including our three businesses: CSL Behring, CSL Seqirus and CSL Vifor – is a global biotechnology leader that develops and delivers innovative lifesaving medicines, protects public health and helps people with life-threatening medical conditions live full lives.

Curare specializes in translational and clinical pharmacology, increasing confidence in therapeutics translation from the bench to clinical proof of concept, and enhancing early stage decision-making.Expertise tailored to your needs, from small biotech to pharma.

Curie.Bio is a $1.2B VC founded to discover and develop important new medicines. We do that by investing directly into existing companies, creating focused spinouts, and helping founders build companies from scratch. Our team of >80 full-time drug hunters provides hands on support to founders.

At CxO, we drive biotech startups toward growth by optimizing resource management and operational efficiency. As partners, we empower firms to innovate and scale. Our veteran team offers strategic insights to accelerate timelines, optimize ROI, and enhance workflows, ensuring client success

Debiopharm is an independent biopharmaceutical company based in Switzerland with an ongoing commitment to improve patient outcomes and quality of life in oncology and bacterial infections. Our main activities include drug development, drug manufacturing and digital health investment.

Delta Medical, based in Zurich, specializes in pharmaceutical marketing, distribution, regulatory affairs, market access, and pharmacovigilance, serving Ukraine and Eurasian markets with tailored commercialization solutions and strategic partnerships.

Devintec Pharma is focused on B2B partnerships through out-licensing innovative substance-based medical devices. We apply DevinPro™ technology, that addresses root causes and creates a protective barrier for lasting relief, to our patended products in gastroenterology, dermatology, and gynecology.

DIAMANTE is a boutique business and management consulting company dedicated to biotech/ pharma clients, diagnostics companies and investors in healthcare. We support companies to streamline product design and development, and work with investors to accelerate and de-risk their selected assets.

DiNAQOR has developed a proprietary technology platform and manufacturing capabilities designed to overcome the challenges and limitations of early-stage gene therapy development.

DKSH is a global distribution and strategic solutions partner for life science and industrial specialties. We provide innovative and sustainable pharmaceutical and biopharmaceutical ingredients to manufacturers across Asia, Europe, and North America.

DrM Group (Dr. Mueller AG) designs and manufactures advanced filtration systems, vibratory mixers, and single-use technologies for solid/liquid separation and processing. Headquartered in Switzerland, we serve the biotech, pharmaceutical, chemical, and food industries worldwide.

Ectica Technologies supplies hydrogel-based tools to the biopharmaceutical and life science industries for drug discovery and bioresearch applications. Ectica Technologies manufactures and supplies the 3DProSeed product line for drug discovery and research in oncology, immuno-oncology and neurosciences. It en

We are offering worldwide professional medical writing and related services to the pharmaceutical (human & veterinary), biotech, medical device and other industries, CROs and academic institutions. With over 20 years of experience in the field, we guarantee the best possible medical writing.

ENABLE Biotech aims to partner with companies from research to clinical stage to address specific challenges of manufacturing Advanced Therapies. Our next generation CDMO model enables an attractive pricing structure and expertise in CMC for speed to Phase I/IIa.

Enantios is a Swiss startup revolutionizing molecular characterization with in-solution structural analysis of chiral complex molecules and Antibody drug Conjugates (ADCs). Enantios delivers solutions for quality control and drug development in pharmaceutical, biotech, and chemical industries.

Enzene is a fully integrated CIDMO with sites in Pune (India) & New Jersey (USA), offering discovery to commercial supply. Its EnzeneX™ FCCM™ tech leads next-gen biologics, aiming to cut mAb costs below $40/g by 2025. Learn more at www.enzene.com.

At EY, we are proud to be driven by our purpose to build a better working world, helping to create long-term value for our clients, people, and communities. As a trusted partner, we leverage our experience, knowledge, and services around the world.

Eurofins BioPharma Product Testing offers complete GMP Testing Services for the Bio/Pharmaceutical industry, including all starting materials, process intermediates, drug substances, drug product, packaging, and manufacturing support through our broad technical expertise.

Eviden is an Atos business that brings together its digital, cloud and big data & security business lines. It will be a global leader in data-driven, trusted and sustainable digital transformation.

EVIIVE develops single extracellular vesicle-based diagnostics to predict immunotherapy response and monitor tumor microenvironment in real time. Our platform integrates advanced flow analytics and machine learning for precision oncology applications.

Preclinical Safety/Toxicology and Strategic Regulatory Consulting for biotech startups with focus from preclinic to first-in-human trial.

EspeRare is an ethical non-profit biotech. It combines pharmaceutical know-how and philanthropic and public investments to bring to life treatments that have been abandoned by the pharmaceutical industry. EspeRare represents an affordable alternative to the high cost innovation of medicines.

Fortrea (formerly Labcorp Drug Development/ Covance) is a leading global provider of clinical development and patient access solutions to the life sciences industry. We provide phase I-IV clinical trial management, clinical pharmacology, technology enabled trial solutions and post-approval services.

Biotech venture builder (VC)

Future Health Pharma GmbH represents companies in Switzerland and distributes and markets their products in CH, UK and EU. We act as Marketing Authorisation Holder or establish their affiliate in CH and EU. We also hold an establishment license to handle controlled substances (narcotics) & vaccines.

Genedata transforms biopharma data into intelligence by combining deep science, technology, and AI domain knowledge. From early discovery to the clinic, the Genedata Biopharma Platform digitalizes and automates complex data workflows, driving innovation and data-based decisions to maximize ROI.

Fasteris is the LifeScience brand of Genesupport SA, that offers DNA-sequencing services to LifeScience companies and research. Genesupport SA offers a complete service in the field of human genetics (prenatal, paediatric and adult), delivered by FMH and FAMH specialists.

GlycoEra is developing biologics to selectively degrade autoimmune disease causing circulating proteins rapidly, selectively, and deeply while avoiding broader dampening of the immune system. This offers many potential benefits over existing broad-spectrum immune-suppressing therapies.

GMP4U is offering engineering and consulting services for the life sciences industry. As experts in qualification and validation, we support our clients in ensuring GMP compliance for production equipment, laboratory instruments, and information management systems.

Clinical-stage biotech company developing next-generation allosteric therapies. Its candidate, GT-02287, is in P1b trials for PD with potential in other neurodegenerative and lysosomal storage disorders. The pipeline also includes preclinical programs targeting metabolic diseases and solid tumors.

GTP Bioways is a French-based CDMO that prioritizes customized services supporting biopharmaceutical companies throughout their journey from R&D to clinics. With more than 20 years’ experience, we specialize in process development and GMP manufacturing of biologics, bioconjugates and nanodrugs.

HBM Partners is a Swiss healthcare investor with over $2.5 billion assets under management. HBM Partners was founded in 2001 with the goal to invest in emerging private and public biopharma and other healthcare companies. HBM Partners is regulated by FINMA and manages SIX listed HBM Healthcare Investments (ww

Founded in 2012, headcount is a Swiss recruitment agency specializing in Biotech, Medtech, Pharma, and Digital Health. We combine scientific expertise with recruitment excellence to connect top talent with leading companies, ensuring a perfect cultural and professional fit.

Swiss-based Life Sciences consultancy and part of the athagoras Group. We enable European market access for pharma & biotech, combining strategy, evidence generation and HTA expertise, from valuation and trial design to reimbursement, JSC, JCA and pricing negotiations.

HekeTiss, a UNIGE/HUG spin-off, enhances lives by pioneering cell-therapy treatments for ulcerative skin conditions. Innovating for a healthier tomorrow.

Helsinn is a global pharmaceutical company that builds, manufactures, launches, and commercializes products to improve the quality of life for patients with cancer and chronic disease, with a focus on supportive care, oncology and dermato-oncology.

Hettich AG, based in Bäch, Switzerland, has supplied laboratory equipment since 1977. We develop and distribute Hettich instruments and represent Memmert, Helmer, B Medical Systems and delta T, supporting life science customers with expertise, reliability and local service.

HGF GmbH is one of Europe’s largest firms of IP specialists. With a dynamic and forward-thinking growth strategy, the firm is one of the few to offer clients a fully integrated IP solution, with 25 offices throughout the UK, Ireland, the Netherlands, Germany, Switzerland, France, and Austria.

We offer a integrated service model in the special areas of corporate transactions, international and local accounting & reporting as well as tax, from start-up to IPO or sale. We focus on M&A and CFO services including interim management.

With 30 years' experience, ICARE stands out as a leader in international standardisation and regulation. We guide healthcare industry through the complex regulatory landscape, ensuring that every healthcare device and product is marketed in full compliance and safety.

ICE Biopharma has 2 core businesses: in-licensing specialty and rare disease drugs for Europe and Canada, and operational consultancy to companies evaluating international Commercialization options. We want European and Canadian patients to have access to the breakthrough therapies they deserve.

iCure offers the Cardinal platform for developing digital health applications that comply with cybersecurity standards, with end-to-end encryption, FHIR interoperability, and open-source SDKs, accelerating innovation in e-health. iCure is ISO27001,ISO13485,HDS certified and GDPR and NIS2 compliant.

The purpose of Idorsia is to discover, develop and bring more, innovative medicines to patients. We have more ideas, we see more opportunities and we want to help more patients.